Anina and Elena have invited Daniel Thoma from the University of Zurich for the third episode of our podcast. They talk to him about the highly controversial topic of preclinical research, how it has changed over time, where there is still value in conducting preclinical research, and where it has been replaced. Furthermore, they also discuss regulations, limitations, and why transferring the results to humans is difficult.